Primary glioblastomas are characterized by PTEN tumor suppressor mutations/deletions, EGFR amplification and TERT promoter mutations, whereas secondary glioblastomas frequently have mutations/deletions of IDH1/2, TP53 and ATRX [4]. This evidence concerns the gene IDH1 and glioblastoma.